Medtronic receives CE mark approval and FDA clearance for its LINQ 2 insertable cardiac monitor

Medical Devices

Medtronic has recently received CE mark approval and Food and Drug Administration clearance for its LINQ 2 insertable cardiac monitor (ICM) with remote programming, which allows clinicians to optimise device settings without the need for patients to return to the hospital or office.

The LINQ 2 system, which is one-third of the size of a triple-A battery, aims to deliver enhanced precision to accurately detect abnormal heart rhythms and last four and a half years.

“Medtronic receives CE mark approval and FDA clearance for its LINQ 2 insertable cardiac monitor.“

Chief Medical Officer of the Cardiac Rhythm and Heart Failure division – part of the Cardiac and Vascular Group, Medtronic, Rob Kowal, stated: “In the current COVID-19 environment, the LINQ 2 system offers patients a seamless way to experience ongoing connectivity between their device and their physician while reducing the need for in office visits. LINQ 2 gives physicians actionable data to help diagnose underlying heart conditions and define treatment protocols for patients with atrial fibrillation or other abnormal heart rhythms.”

See all the latest jobs in Medical Devices
Return to news